Mentoring in advanced mHealth interventions for drug abuse and HAART adherence

指导针对药物滥用和 HAART 依从性的先进移动医疗干预措施

基本信息

  • 批准号:
    9446608
  • 负责人:
  • 金额:
    $ 18.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This K24 proposal builds on my strong record of successful mentoring and original investigation to generate research capacity in the area of mobile technologies to improve health (mHealth). I have mentored 21 clinician-scientists, 15 of whom have been awarded NIH funding under K23, K08, R01, R21, R03, Loan Repayment Program, and Minority Supplement mechanisms. Of the 16 clinician-scientists whom I currently mentor, 12 have engaged in mHealth-related research. My responsibilities in the University of Massachusetts (UMass) CTSA-funded mentoring programs, my collaborations with the NIDA-funded P30 Center for Technology and Behavioral Health at Dartmouth Medical School, referrals from NIDA program staff, and other efforts have expanded the scope of my mentoring and ensured a nationwide source of mentees. My patient-oriented research focuses on mHealth approaches to substance abuse treatment and improving medication adherence in persons with HIV. The striking increase in the use of mobile technologies has created great opportunities for delivery of health interventions in natural environments at the time and location they are needed most. Despite the broad reach, multimedia capabilities, and computing power of mobile technologies, several features threaten the acceptability of smartphone-delivered behavioral interventions and detract from their enormous potential as effective health promotion tools. The ultimate goal of this proposal, therefore, is to create mobile technology-driven interventions capable of producing persistent beneficial health effects. The overall research goal of the K24 is to develop new classes of mHealth behavioral interventions through three synergistic research thrusts. The first involves the development of advanced mHealth behavioral interventions that support long-term abstinence, prevent relapse, and promote antiretroviral adherence in HIV+ patients. The second involves development of mobile biosensing methods that can assess the effectiveness of these highly innovative interventions by identifying the onset and duration of drug use episodes. In a third line of investigation, I intend to elucidate the design elements that will maximize the usability and acceptability of novel mHealth behavioral interventions. The overall mentoring objective of this K24 is to develop researchers who not only have the skills to develop, implement, and publish hypothesis driven, patient-oriented mHealth research, but who understand the importance of bringing a multi-method, multi-disciplinary approach to clinical and translational research problems. My mentoring approach emphasizes the importance of tailoring research methods to the nature of the problem of interest, even if that means learning new behavioral science, engineering, and clinical research methods or developing collaborations with investigators from other disciplines familiar with those methods. The proposed research is relevant to the NIH's mission because the lessons learned from this drug abuse- and HIV-related work are directly applicable to the care of patients with other common, intractable, and expensive conditions amenable to behavioral interventions.
描述(由申请人提供):这个K24建议建立在我成功的指导和原始调查的良好记录,以产生在移动的技术领域的研究能力,以改善健康(mHealth)。我指导了21名临床科学家,其中15人获得了K23,K08,R01,R21,R03,贷款偿还计划和少数民族补充机制下的NIH资金。在我目前指导的16位临床科学家中,有12位从事与移动健康相关的研究。我在马萨诸塞州大学(UMass)CTSA资助的辅导项目中的职责,我与达特茅斯医学院NIDA资助的P30技术和行为健康中心的合作,NIDA项目工作人员的推荐,以及其他努力扩大了我的辅导范围,并确保了全国范围的学员来源。我以患者为导向的研究重点是mHealth方法来治疗药物滥用和提高艾滋病毒感染者的药物依从性。移动的技术的使用显著增加,为在最需要的时间和地点在自然环境中提供卫生干预措施创造了巨大的机会。尽管移动的技术具有广泛的覆盖范围、多媒体功能和计算能力,但有几个特征威胁到智能手机提供的行为干预的可接受性,并减损其作为有效健康促进工具的巨大潜力。因此,本提案的最终目标是创造能够产生持久有益健康影响的移动的技术驱动的干预措施。K24的总体研究目标是通过三个协同研究重点开发新的移动健康行为干预措施。第一个是开发先进的移动健康行为干预措施,支持长期禁欲,预防复发,并促进艾滋病毒+患者的抗逆转录病毒治疗依从性。第二个涉及开发移动的生物传感方法,通过确定吸毒发作的开始和持续时间,评估这些高度创新的干预措施的有效性。在第三条调查路线中,我打算阐明设计元素, 将最大限度地提高新型移动健康行为干预的可用性和可接受性。K24的总体指导目标是培养研究人员,他们不仅具有开发,实施和发布假设驱动,以患者为导向的移动健康研究的技能,而且了解将多方法,多学科方法应用于临床和转化研究问题的重要性。我的指导方法强调根据感兴趣的问题的性质定制研究方法的重要性,即使这意味着学习新的行为科学,工程和临床研究方法,或者与熟悉这些方法的其他学科的研究人员进行合作。拟议的研究与NIH的使命相关,因为从药物滥用和HIV相关工作中吸取的经验教训可直接应用于其他常见,棘手和昂贵的条件下接受行为干预的患者的护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward W Boyer其他文献

Edward W Boyer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward W Boyer', 18)}}的其他基金

Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
  • 批准号:
    10529984
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
  • 批准号:
    10668451
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
  • 批准号:
    10469618
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users
MyTPill:监测 HIV 处方阿片类药物使用者抗逆转录病毒依从性的新策略
  • 批准号:
    10116617
  • 财政年份:
    2019
  • 资助金额:
    $ 18.69万
  • 项目类别:
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users
MyTPill:监测 HIV 处方阿片类药物使用者抗逆转录病毒依从性的新策略
  • 批准号:
    10381648
  • 财政年份:
    2019
  • 资助金额:
    $ 18.69万
  • 项目类别:
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users
MyTPill:监测 HIV 处方阿片类药物使用者抗逆转录病毒依从性的新策略
  • 批准号:
    10550038
  • 财政年份:
    2019
  • 资助金额:
    $ 18.69万
  • 项目类别:
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users
MyTPill:监测 HIV 处方阿片类药物使用者抗逆转录病毒依从性的新策略
  • 批准号:
    10380990
  • 财政年份:
    2019
  • 资助金额:
    $ 18.69万
  • 项目类别:
NIDA National Early Warning System Network (iN3): An Innovative Approach
NIDA 国家预警系统网络 (iN3):创新方法
  • 批准号:
    8777695
  • 财政年份:
    2014
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mentoring in advanced mHealth interventions for drug abuse and HAART adherence
指导针对药物滥用和 HAART 依从性的先进移动医疗干预措施
  • 批准号:
    8789850
  • 财政年份:
    2014
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
  • 批准号:
    10258162
  • 财政年份:
    2014
  • 资助金额:
    $ 18.69万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 18.69万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 18.69万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 18.69万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 18.69万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 18.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了